Risk Factors for Acute Prostatitis after Transrectal Biopsy of the Prostate

다국어 초록 (Multilingual Abstract)

Purpose: To investigate the incidence, clinical features, pathogenic bacteria, and risk factors associated with acute prostatitis after transrectal prostate biopsy.
Materials and Methods: We retrospectively reviewed the medical records of 923 transrectal ultrasound-guided needle biopsies of the prostate in 878 patients performed at our institution from June 2004 to May 2009. The indications for biopsy were generally serum prostate-specific antigen (PSA) elevation, abnormal findings on a digital rectal examination, or both. All biopsies were performed with the patient hospitalized except for 10 patients who refused to be hospitalized, and ciprofloxacin was administered as an antibiotic prophylaxis. The incidence, clinical features, pathogenic bacteria, and potential risk factors associated with acute prostatitis after prostate biopsy were evaluated.
Results: Acute prostatitis developed in 18 (2.0%) cases after prostate biopsy. Among them, 9 (1.0%) had bacteremia and 2 (0.2%) showed clinical features of sepsis. Of the total 50 urine or blood specimens sent for culture study, 27 (54.0%) specimens showed positive cultures, including E. coli in 25. Among the 27 culture-positive specimens, 26 (96.3%) were resistant to ciprofloxacin. Among the potential risk factors for acute prostatitis after prostate biopsy, biopsy performed as an outpatient procedure without a cleansing enema (p=0.001) and past history of cerebrovascular accident (p=0.048) were statistically significant.
Conclusions: Fluoroquinolone is effective as an antibiotic prophylaxis for transrectal prostate biopsy in most cases. The incidence of acute prostatitis after transrectal prostate biopsy was 2.0%, and almost all cases were caused by fluoroquinolone-resistant E. coli. A cleansing enema is recommended before transrectal prostate biopsy.

다국어 초록 (Multilingual Abstract)

Purpose: To investigate the incidence, clinical features, pathogenic bacteria, and risk factors associated with acute prostatitis after transrectal prostate biopsy.
Materials and Methods: We retrospectively reviewed the medical records of 923 transrectal ultrasound-guided needle biopsies of the prostate in 878 patients performed at our institution from June 2004 to May 2009. The indications for biopsy were generally serum prostate-specific antigen (PSA) elevation, abnormal findings on a digital rectal examination, or both. All biopsies were performed with the patient hospitalized except for 10 patients who refused to be hospitalized, and ciprofloxacin was administered as an antibiotic prophylaxis. The incidence, clinical features, pathogenic bacteria, and potential risk factors associated with acute prostatitis after prostate biopsy were evaluated.
Results: Acute prostatitis developed in 18 (2.0%) cases after prostate biopsy. Among them, 9 (1.0%) had bacteremia and 2 (0.2%) showed clinical features of sepsis. Of the total 50 urine or blood specimens sent for culture study, 27 (54.0%) specimens showed positive cultures, including E. coli in 25. Among the 27 culture-positive specimens, 26 (96.3%) were resistant to ciprofloxacin. Among the potential risk factors for acute prostatitis after prostate biopsy, biopsy performed as an outpatient procedure without a cleansing enema (p=0.001) and past history of cerebrovascular accident (p=0.048) were statistically significant.
Conclusions: Fluoroquinolone is effective as an antibiotic prophylaxis for transrectal prostate biopsy in most cases. The incidence of acute prostatitis after transrectal prostate biopsy was 2.0%, and almost all cases were caused by fluoroquinolone-resistant E. coli. A cleansing enema is recommended before transrectal prostate biopsy.

참고문헌 (Reference)

1 이상은, "전립선암의 진단" 대한비뇨기과학회 45 (45): 197-208, 2004

2 채윤병, "경회음부와 경직장전립선생검술의 비교" 대한비뇨기과학회 50 (50): 119-124, 2009

3 강민용, "경직장초음파 전립선침생검: 시술 전 관장의 유효성" 대한비뇨기과학회 49 (49): 248-251, 2008

4 전상봉, "경직장 초음파 유도 41부위 전립선 생검법" 대한비뇨기과학회 49 (49): 122-126, 2008

5 장훈아, "경직장 전립선 생검 후 발생한 감염성 합병증의 위험인자와 배양된 균주의 특징" 대한남성과학회 26 (26): 212-217, 2008

6 Shandera KC, "Variability in patient preparation for prostate biopsy among American urologists" 52 : 644-646, 1998

7 Ramey JR, "Ultrasonography and biopsy of the prostate. In: Campbell-Walsh urology. 9th ed" Saunders 2883-2895, 2007

8 Carey JM, "Transrectal ultrasound guided biopsy of the prostate. Do enemas decrease clinically significant complications?" 166 : 82-85, 2001

9 Lee G, "Trans-rectal ultrasound guided biopsy of the prostate: nationwide diversity in practice and training in the United Kingdom" 39 : 185-188, 2007

10 Feliciano J, "The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis?" 179 : 952-955, 2008

11 Djavan B, "Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study" 166 : 856-860, 2001

12 de la Rosette JJ, "Optimizing prostate cancer detection: 8 versus 12-core biopsy protocol" 182 : 1329-1336, 2009

13 Enlund AL, "Morbidity of ultrasound-guided transrectal core biopsy of the prostate without prophylactic antibiotic therapy. A prospective study in 415 cases" 79 : 777-780, 1997

14 Chiang IN, "Major complications and associated risk factors of transrectal ultrasound guided prostate needle biopsy: a retrospective study of 1875 cases in Taiwan" 106 : 929-934, 2007

15 Nam RK, "Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy" 183 : 963-968, 2010

16 Özden E, "Incidence of acute prostatitis caused by extended- spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy" 74 : 119-123, 2009

17 Tal R, "Empirical management of urinary tract infections complicating transrectal ultrasound guided prostate biopsy" 169 : 1762-1765, 2003

18 Sieber PR, "Contemporary prostate biopsy complication rates in community-based urology practice" 70 : 498-500, 2007

19 Ecke TH, "Complications and risk factors of transrectal ultrasound guided needle biopsies of the prostate evaluated by questionnaire" 26 : 474-478, 2008

20 Raaijmakers R, "Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population- based screening program" 60 : 826-830, 2002

21 Berger AP, "Complication rate of transrectal ultrasound guided prostate biopsy: a comparison among 3 protocols with 6, 10 and 15 cores" 171 : 1478-1480, 2004

22 Krogh K, "Colorectal symptoms in patients with neurological diseases" 103 : 335-343, 2001

23 Bracci F, "Chronic constipation in hemiplegic patients" 13 : 3967-3972, 2007

24 Lindert KA, "Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy" 164 : 76-80, 2000

25 Brown RW, "Bacteremia and bacteriuria after transrectal prostatic biopsy" 18 : 145-148, 1981

26 Cormio L, "Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective study of ciprofloxacin vs piperacillin/tazobactam" 90 : 700-702, 2002

27 Sieber PR, "Antibiotic prophylaxis in ultrasound guided transrectal prostate biopsy" 157 : 2199-2200, 1997

28 Yamamoto S, "Antibiotic prophylaxis for transrectal prostate biopsy: a prospective randomized study of tosufloxacin versus levofloxacin" 15 : 604-606, 2008

29 Aron M, "Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study" 85 : 682-685, 2000

30 Shigehara K, "Acute bacterial prostatitis after transrectal prostate needle biopsy: clinical analysis" 14 : 40-43, 2008